KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Liabilities from Discontinued Operations (2023 - 2025)

Emergent BioSolutions' Liabilities from Discontinued Operations history spans 4 years, with the latest figure at 4500000.0 for Q3 2025.

  • For Q3 2025, Liabilities from Discontinued Operations changed N/A year-over-year to 4500000.0; the TTM value through Sep 2025 reached 4500000.0, changed N/A, while the annual FY2015 figure was 17348000.0, N/A changed from the prior year.
  • Liabilities from Discontinued Operations reached 4500000.0 in Q3 2025 per EBS's latest filing, down from 4700000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 37500000.0 in Q1 2023 to a low of 4500000.0 in Q3 2025.
  • Average Liabilities from Discontinued Operations over 3 years is 12320000.0, with a median of 4800000.0 recorded in 2025.
  • The largest YoY upside for Liabilities from Discontinued Operations was 53.47% in 2025 against a maximum downside of 53.47% in 2025.
  • A 3-year view of Liabilities from Discontinued Operations shows it stood at 37500000.0 in 2023, then plummeted by 73.07% to 10100000.0 in 2024, then crashed by 55.45% to 4500000.0 in 2025.
  • Per Business Quant, the three most recent readings for EBS's Liabilities from Discontinued Operations are 4500000.0 (Q3 2025), 4700000.0 (Q2 2025), and 4800000.0 (Q1 2025).